Primary Acinic Cell Carcinoma of the Breast: A Clinicopathological and Immunohistochemical Study

Table 1

Clinical characteristics of acinic cell carcinoma of the breast.

Nr.	References	Age  (years)	Gender	Tumor size  (mm)	LN metastases	Operation	Adjuvant therapy	Follow-up  (years)	Recurrence
1	Roncaroli et al. [1]	42	F	30	1/18	Bt + Ax	CT	5	—
2	Shimao et al. [2]	23	M	48	—	Bt + Ax	Not known	2.8	—
3	Damiani et al. [3]	35	F	40	2/20	Bt + Ax	CT	1	—
4	[3]	63	F	50	Not known	BCS	—	4	Local
5	[3]	55	F	20	Not known	BCS	—	Not known	Not known
6	[3]	64	F	33	0/8	BCS + Ax	—	1	—
7	[3]	80	F	20	Not known	BCS	HT	1	—
8	Schmitt et al. [4]	79	F	45	0/23	Bt + Ax	RT	1.7	—
9	Coyne and Dervan [5]	49	F	20	2/11	Bt + Ax	CT	3	Liver (died)
10	Elster et al. [6]	48	F	30	0/6	BCS + Ax	CT + RT	Not known	Not known
11	Peintinger et al. [7]	36	F	35	0/15	BCS + Ax	CT + RT	10	Lung
12	Tanahashi et al. [8]	80	F	30	—	Bt + SN	Not known	1.8	—
13	Chang et al. [9]	39	F	55	1/Not known	BCS + Ax	Not known	Not known	Not known
14	Choh et al. [10]	79	F	27	—	BCS + SN	RT	0.8	—
15	Present case	41	F	25	0/1	BCS + SN	CT + RT	3	—

Bt:  total mastectomy; BCS: breast-conserving surgery; Ax: axillary lymph nodes dissection; SN: sentinel lymph node biopsy; CT: chemotherapy; HT: hormone therapy; RT: radiotherapy.